Looijenga Leendert H J, Zafarana Gaetano, Grygalewicz Beata, Summersgill Brenda, Debiec-Rychter Maria, Veltman Joris, Schoenmakers Eric F P M, Rodriguez Sandrine, Jafer Osman, Clark Jeremy, van Kessel Ad Geurts, Shipley Janet, van Gurp Ruud J H L M, Gillis Ad J M, Oosterhuis J Wolter
Pathology/Lab. for Exp. Patho-Oncology, Erasmus MC/Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.
APMIS. 2003 Jan;111(1):161-71; discussion 172-3. doi: 10.1034/j.1600-0463.2003.11101201.x.
Within the human testis, three entities of germ cell tumours are distinguished: the teratomas and yolk sac tumors of newborn and infants, the seminomas and nonseminomas of adolescents and young adults, referred to as testicular germ cell tumours (TGCT), and the spermatocytic seminomas. Characteristic chromosomal anomalies have been reported for each group, supporting their distinct pathogenesis. TGCT are the most common cancer in young adult men. The initiating pathogenetic event of these tumours occurs during embryonal development, affecting a primordial germ cell or gonocyte. Despite this intra-uterine initiation, the tumour will only be clinically manifest after puberty, with carcinoma in situ (IS) as the precursor. All invasive TGCT, both seminomas and nonseminomas, as well as CIS cells are aneuploid. The only consistent (structural) chromosomal abnormalities in invasive TGCT are gains of the short arm of chromosome 12, mostly due to isochromosome (i(12p)) formation. This suggests that an increase in copy number of a gene(s) on 12p is associated with the development of a clinically manifest TGCT. Despite the numerous (positional) candidate gene approaches that have been undertaken thus far, identification of a causative gene(s) has been hampered by the fact that most 12p gains involve rather large genomic intervals, containing unmanageable numbers of candidate genes. Several years ago, we initiated a search for 12p candidate genes using TGCT with a restricted 12p-amplification, cytogenetically identified as 12p11.2-p12.1. This approach is mainly based on identification of candidate genes mapped within the shortest region of overlap of amplification (SROA). In this review, data will be presented, which support the model that gain of 12p-sequences is associated with suppression of apoptosis and Sertoli cell-independence of CIS cells. So far, DAD-R is one of the most likely candidate genes involved in this process, possibly via N-glycosylation. Preliminary results on high through-put DNA- and cDNA array analyses of 12p-sequences will be presented.
在人类睾丸中,生殖细胞肿瘤可分为三类:新生儿和婴儿的畸胎瘤及卵黄囊瘤;青少年和年轻成年人的精原细胞瘤和非精原细胞瘤,统称为睾丸生殖细胞肿瘤(TGCT);以及精母细胞性精原细胞瘤。已报道每组都有特征性的染色体异常,这支持了它们不同的发病机制。TGCT是年轻成年男性中最常见的癌症。这些肿瘤的起始发病事件发生在胚胎发育期间,影响原始生殖细胞或生殖母细胞。尽管肿瘤在子宫内就已起始,但直到青春期后才会临床显现,原位癌(CIS)是其前驱病变。所有侵袭性TGCT,包括精原细胞瘤和非精原细胞瘤,以及CIS细胞都是非整倍体。侵袭性TGCT中唯一一致的(结构)染色体异常是12号染色体短臂的增加,主要是由于等臂染色体(i(12p))的形成。这表明12p上一个或多个基因的拷贝数增加与临床显性TGCT的发生有关。尽管迄今为止已经采用了众多(定位)候选基因方法,但由于大多数12p增加涉及相当大的基因组区间,包含数量难以处理的候选基因,导致致病基因的鉴定受到阻碍。几年前,我们开始使用细胞遗传学鉴定为12p11.2 - p12.1的受限12p扩增的TGCT来寻找12p候选基因。这种方法主要基于鉴定映射在扩增最短重叠区域(SROA)内的候选基因。在本综述中,将展示支持12p序列增加与CIS细胞凋亡抑制和支持细胞独立性相关模型的数据。到目前为止,DAD - R是参与此过程的最可能候选基因之一,可能是通过N - 糖基化作用。还将展示关于12p序列的高通量DNA和cDNA阵列分析的初步结果。